Vials of Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weigh loss, are placed on a table for a photograph in a health clinic in Hyderabad, India, April 14, 2025. REUTERS.
A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS
Aug 13 (Reuters) – Eli Lilly launched the pre-filled injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India on Wednesday, stepping up competition with rival Novo Nordisk.
Reporting by Kashish Tandon in Bengaluru; Editing by Janane Venkatraman
